Literature DB >> 12525926

Retrospective analysis of the first clonal outbreak of nalidixic acid-resistant Shigella sonnei shigellosis in Israel.

D Dagan1, N Orr, M Yavzori, Y Yuhas, D Meron, S Ashkenazi, D Cohen.   

Abstract

Reported here is a retrospective molecular analysis of the isolates recovered from the first outbreak of nalidixic acid (NA)-resistant Shigella sonnei shigellosis to occur in Israel. The outbreak affected 94 children. In the retrospective analysis, a total of 13 NA-resistant isolates and five NA-susceptible isolates recovered during the outbreak period were examined. Restriction fragment length polymorphism profiles obtained by digestion with BamHI, PvuI, HinfI or SmaI yielded identical profiles for all 18 isolates. All NA-resistant strains had an identical plasmid profile, but this profile differed from that displayed by the susceptible strains. In all of the NA-resistant strains a 304 bp fragment in the gyrA gene coding for a region associated with NA resistance was sequenced and showed a single point mutation, Ser83-->Phe. In this outbreak, the isolates of NA-resistant Shigella sonnei belonged to a single clone and NA resistance was associated with a point mutation in the gyrA gene.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12525926     DOI: 10.1007/s10096-002-0843-9

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  14 in total

1.  Four decades of shigellosis in Israel: epidemiology of a growing public health problem.

Authors:  M S Green; C Block; D Cohen; P E Slater
Journal:  Rev Infect Dis       Date:  1991 Mar-Apr

2.  Antimicrobial resistance and serotypes of Shigella isolates in Kigali, Rwanda (1983 to 1993): increasing frequency of multiple resistance.

Authors:  J Bogaerts; J Verhaegen; J P Munyabikali; B Mukantabana; P Lemmens; J Vandeven; J Vandepitte
Journal:  Diagn Microbiol Infect Dis       Date:  1997-08       Impact factor: 2.803

3.  Shigellosis in Israel--update 1995.

Authors:  P Ostroi; E Anis; M S Green
Journal:  Public Health Rev       Date:  1996

4.  Contributions of individual mechanisms to fluoroquinolone resistance in 36 Escherichia coli strains isolated from humans and animals.

Authors:  M J Everett; Y F Jin; V Ricci; L J Piddock
Journal:  Antimicrob Agents Chemother       Date:  1996-10       Impact factor: 5.191

5.  Analysis of the mechanism of quinolone resistance in nalidixic acid-resistant clinical isolates of Salmonella serotype Typhimurium.

Authors:  J Ruiz; D Castro; P Goñi; J A Santamaria; J J Borrego; J Vila
Journal:  J Med Microbiol       Date:  1997-07       Impact factor: 2.472

6.  Therapy for shigellosis. I. Randomized, double-blind trial of nalidixic acid in childhood shigellosis.

Authors:  M A Salam; M L Bennish
Journal:  J Pediatr       Date:  1988-11       Impact factor: 4.406

7.  Involvement of an efflux system in high-level fluoroquinolone resistance of Shigella dysenteriae.

Authors:  A S Ghosh; J Ahamed; K K Chauhan; M Kundu
Journal:  Biochem Biophys Res Commun       Date:  1998-01-06       Impact factor: 3.575

8.  Molecular epidemiology of Shigella infections in Israel.

Authors:  M Yavzori; D Cohen; H Bercovier
Journal:  Epidemiol Infect       Date:  1992-10       Impact factor: 2.451

9.  Mutations in gyrA gene of quinolone-resistant Salmonella serotypes isolated from humans and animals.

Authors:  D J Griggs; K Gensberg; L J Piddock
Journal:  Antimicrob Agents Chemother       Date:  1996-04       Impact factor: 5.191

10.  Shigella infections in the United States, 1974-1980.

Authors:  M J Blaser; R A Pollard; R A Feldman
Journal:  J Infect Dis       Date:  1983-04       Impact factor: 5.226

View more
  2 in total

1.  Antimicrobial susceptibility of Shigella sonnei isolates in Japan and molecular analysis of S. sonnei isolates with reduced susceptibility to fluoroquinolones.

Authors:  Kenji Hirose; Jun Terajima; Hidemasa Izumiya; Kazumichi Tamura; Eiji Arakawa; Nobuko Takai; Haruo Watanabe
Journal:  Antimicrob Agents Chemother       Date:  2005-03       Impact factor: 5.191

2.  Epidemiology of nalidixic acid resistance and TEM-1- and TEM-52-mediated ampicillin resistance of Shigella sonnei isolates obtained in Korea between 1980 and 2000.

Authors:  Young Sook Jeong; Je Chul Lee; Hee Young Kang; Hak Sun Yu; Eun Young Lee; Chul Hee Choi; Seong Ho Tae; Yoo Chul Lee; Dong Taek Cho; Sung Yong Seol
Journal:  Antimicrob Agents Chemother       Date:  2003-12       Impact factor: 5.191

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.